Triple
T5114927
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Memantine |
E115307
|
entity |
| Predicate | isMarketedUnderBrandName |
P40804
|
FINISHED |
| Object |
Namenda
Namenda is a prescription medication used to treat moderate to severe Alzheimer's disease by regulating the activity of glutamate in the brain.
|
E494105
|
NE FINISHED |
How this triple was built (5 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Namenda | Statement: [Memantine, isMarketedUnderBrandName, Namenda]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Namenda Context triple: [Memantine, isMarketedUnderBrandName, Namenda]
-
A.
Donepezil
Donepezil is a cholinesterase inhibitor medication primarily used to treat cognitive symptoms of Alzheimer's disease.
-
B.
Toclafane
The Toclafane are a race of deadly, cybernetic spheres revealed to be the future remnants of humanity in the Doctor Who universe, serving as instruments of mass destruction under the Master.
-
C.
rivastigmine
Rivastigmine is a cholinesterase inhibitor medication used to manage symptoms of mild to moderate dementia, particularly in Alzheimer's and Parkinson's disease.
-
D.
riluzole
Riluzole is a neuroprotective medication that modestly prolongs survival and slows disease progression in people with amyotrophic lateral sclerosis (ALS).
-
E.
amantadine
Amantadine is an antiviral and antiparkinsonian medication used to help manage motor symptoms such as tremor and rigidity in people with Parkinson’s disease.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Namenda Triple: [Memantine, isMarketedUnderBrandName, Namenda]
Generated description
Namenda is a prescription medication used to treat moderate to severe Alzheimer's disease by regulating the activity of glutamate in the brain.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Namenda Target entity description: Namenda is a prescription medication used to treat moderate to severe Alzheimer's disease by regulating the activity of glutamate in the brain.
-
A.
Donepezil
Donepezil is a cholinesterase inhibitor medication primarily used to treat cognitive symptoms of Alzheimer's disease.
-
B.
Toclafane
The Toclafane are a race of deadly, cybernetic spheres revealed to be the future remnants of humanity in the Doctor Who universe, serving as instruments of mass destruction under the Master.
-
C.
rivastigmine
Rivastigmine is a cholinesterase inhibitor medication used to manage symptoms of mild to moderate dementia, particularly in Alzheimer's and Parkinson's disease.
-
D.
riluzole
Riluzole is a neuroprotective medication that modestly prolongs survival and slows disease progression in people with amyotrophic lateral sclerosis (ALS).
-
E.
amantadine
Amantadine is an antiviral and antiparkinsonian medication used to help manage motor symptoms such as tremor and rigidity in people with Parkinson’s disease.
- F. None of above. chosen
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: isMarketedUnderBrandName Context triple: [Memantine, isMarketedUnderBrandName, Namenda]
-
A.
hasBrandName
chosen
Indicates that an entity is associated with or identified by a specific brand name.
-
B.
originalMarketingName
Indicates the original marketing or brand name under which an entity (such as a product or service) was first promoted or sold.
-
C.
hasUnderlyingCompanyBrand
Indicates that one entity is associated with or operates under the corporate brand of another company as its underlying brand.
-
D.
hasMarketingCategory
Indicates that an entity is associated with a specific marketing category or segment used for classification or targeting.
-
E.
usedBrand
Indicates that an entity has utilized, applied, or operated a particular brand in some context.
- F. None of above.
Provenance (6 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69bd4441d1648190a54a533895041987 |
completed | March 20, 2026, 12:57 p.m. |
| NER | Named-entity recognition | batch_69bd75ce6044819094166aebf0688665 |
completed | March 20, 2026, 4:29 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69bebaadfaac8190aa0407196e5c4c20 |
completed | March 21, 2026, 3:35 p.m. |
| NEDg | Description generation | batch_69bebb1a4370819085bcbe73a0b8c68e |
completed | March 21, 2026, 3:36 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69bebcf63784819097be14bb7dcbf4d9 |
completed | March 21, 2026, 3:44 p.m. |
| PD | Predicate disambiguation | batch_69bd715fe3a8819087d3065adddba515 |
completed | March 20, 2026, 4:10 p.m. |
Created at: March 20, 2026, 1:41 p.m.